Estimation of cumulative and adjusted occurrence of life events and measures over time is often important in settings where study subjects have incomplete or different follow-up periods. Well-known methods to do this, such as the life table and age adjustment, exist for binary nonrecurrent events (he., death). However, a general approach to evaluate recurrent life events (e.g., repeated infections), life events with different durations (e.g., hospitalization days), costs, or changing life measures (e.g., body weight) is not available. This paper develops the "Life-Event Table, " an analog of the life table that can analyze occurrence of diverse types of events and measures when the observation periods of subjects are incomplete and different. This method, based on a centra) limit theorem for incomplete multivariate data, obtains point estimates and variances for cumulative incidence, age-adjusted expectation, and other quantities. Simple hypotheses tests and comparisons are possible with this approach. Three applications are presented. The Life-Event Estimates of adjusted and cumulative occurrence of longitudinal life events and measures that occur over time are often needed. These events and measures include: 1) binary nonrecurrent events, i.e., death, diagnosis of acquired immunodeficiency syndrome (AIDS); 2) repeating events, e.g., sexually transmitted diseases, lung infections, accidents; 3) events with different durations, e.g., hospital stays, prison incarcerations; 4) costs or other functions of events, e.g., outpatient expenditures; and 5) life measures that vary, e.g., blood pressure, weight, and cholesterol. When the study subjects in the sample have identical follow-up periods, obtaining these estimates is straightforward. For example, let all subjects be completely followed between ages 20 and 40 years. Then, for any subinterval of that age range, the sample mean for outcomes on that subinterval, ±2 times the standard deviation, gives a 95 percent confidence limit for the population mean (1).
Estimates of adjusted and cumulative occurrence of longitudinal life events and measures that occur over time are often needed. These events and measures include: 1) binary nonrecurrent events, i.e., death, diagnosis of acquired immunodeficiency syndrome (AIDS); 2) repeating events, e.g., sexually transmitted diseases, lung infections, accidents; 3) events with different durations, e.g., hospital stays, prison incarcerations; 4) costs or other functions of events, e.g., outpatient expenditures; and 5) life measures that vary, e.g., blood pressure, weight, and cholesterol. When the study subjects in the sample have identical follow-up periods, obtaining these estimates is straightforward. For example, let all subjects be completely followed between ages 20 and 40 years. Then, for any subinterval of that age range, the sample mean for outcomes on that subinterval, ±2 times the standard deviation, gives a 95 percent confidence limit for the population mean (1).
However, identical and complete follow-up rarely occurs. Follow-up is often incomplete since people miss scheduled visits, quit, or move away and covers different time periods since people are enrolled into the study at different starting points. Thus, methods to utilize data from disjoint partial follow-up periods are needed. Life tables (or Kaplan-Meier functions) and standard age-adjusting techniques use data from subjects with different follow-up periods to quantify events (2) (3) (4) . However, these approaches are only useful if the outcome event is binary and nonrecurrent. While analytic methods for repeated and time-varying measures are available (5), these procedures focus on studying associations and covariate effects rather than on estimating adjusted and cumulative occurrences of these events.
A new approach, the Life-Event Table model , is developed here to estimate adjusted and cumulative population occurrence of diverse types of events and measures from individuals with differing follow-up periods. This method is similar to the standard life table, is easily implemented, and obtains various quantifications and hypothesis tests. Extensions to include covariates are possible.
As with the life table, the Life-Event Table 1 shows individual Observation Periods for six individuals in a study of events between ages 20 and 40 years. Individual 1 was observed in k x = two age periods. The first was from 20 (€j ]) to 27 (r } ,) years; the second was from £, 2 = 34 to r, 2 = 40 years. However, information from ages 27 to 34 years is not known for individual 1. The outcome of interest could be discrete (e.g., number of sexually transmitted diseases), involve duration (e.g., number of hospital days), be medical costs, or be measurements (e.g., weight) taken at regular timepoints. Only data from Analysis Intervals on which the individual was completely observed are used. Table 2 illustrates this for our study of medical events or measurements between ages 20 and 40 years. The Analysis Intervals, /,: [20, 25) 
ANALYSIS OF THIS LIFE-EVENT TABLE

Necessary assumptions and definitions
For analysis by the Life-Event Table to be valid; 1) individuals must be randomly and independently sampled; and 2) observation of a subject in an Analysis Interval must be independent of the outcome values on that interval. The section on quantifying outcomes on Individual Analysis Intervals gives a method to test for assumption 2. The quantity of outcomes occurring on [20] [21] [22] [23] [24] [25] Complete* (20- Analysis Interval L must also have finite expectation fXj and variance of. The expected cumulation of outcomes for the entire period [t 0 , t m ) is n T = 1'JL 1 /x,. The within-individual covariance of outcomes on intervals /, and I r is cr, r .
Important summarizing estimates
Let the sets {w,} denote individuals observed on interval /, and the sets {w ir } denote individuals observed on both intervals /, and I r for / = 1,.. ., m and i' # /. Table 4 shows the {w,} and {w it ,} for the data of tables 1-3; {wj} contains {j = l,j = 2, andy = 4}, {w 3 } contains {j = 3J = 5, andy = 6}, and {w 13 } has no members. Let n, and n u . be the number of individuals in the sets {w,} and {w, r }, respectively. In table 4, n l -3, n 3 = 3, and n 13 = 0.
The minimum variance unbiased estimate for /x, and its variance are given by equations 1 and 2 below (6):
The covariance of (L ( and (L t , depends on a iV and the number of "shared" individuals contributing to both estimates:
Usually, of and (T u , will be unknown. The expectations No. Table  5 gives point estimates /I, and covariances of these estimates for the data in tables 1-4.
Large-sample multivariate properties Appendix 1 proves a central limit theorem for incomplete multivariate data that is applicable to the estimates given in the section, Important summarizing estimates. Briefly, if for all i, n,, -> °° as the sample size, n, becomes infinite, then all /I, converge to ix t . If the ratios n/n and n iV ln each converge to some constant, then the vector of \/n (/x, -/x,) i = 1, .. ., m converges to a multivariate normal distribution. Furthermore, SJI> -* a u . if n u , becomes infinite. If n w remains finite, then 5,,. is ignorable, as {S w • n w )l (n,-• «,-.) -^ 0.
ESTIMATION AND TESTING FROM THIS LIFE-EVENT TABLE
Many important estimates and tests can be formulated in terms of 2wr, • /i,, where [wt u wt 2 
, • • •, wt m ]
is a relevant set of weights. As Appendix I shows, (Ly .. ., /l m converges to a multivariate normal distribution, with Sj/rij and (5,,-• ",,')/(«<' n v) approximating the varC/i,) and cov(fi,,,pL r ), respectively. Thus, iwtipL; is approximately normal with a mean S and standard deviation given by formula 6:
wt t wt? (6) Hypothesis testing and confidence limits for Svvf,/x, can be obtained with Gaussian procedures.
Cumulative occurrence
Cumulative incidence of nonrepeating binary events is obtained by the life table (3). The Life-Event Table   TABLE 5 . Point estimates with covariance of mean Interval occurrence for the data in table 3 Covariance matrix Potnt estimates
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Age-(or time period-) adjusted expectation
Incidence of binary nonrepeating events is often adjusted to a standard population age distribution (2) . The Life-Event 
Tests of individual differences
It may be important to know whether outcome mean occurrence systematically differs by individual. Let H o be the (a priori) null hypothesis that for all i,j, and/, M*/ / = M-(/' » and H a be some specific alternative. Let P tj be chosen so that P tj . > P tj means that under H a , \Ly > iLy. Let P, be the mean of Py for individuals in {w,}, D t be some constant, and Xfi) = D t {Py -PJXfi). Under H o , E[Xp)] = 0, (i.e., /Xy-= 0), and in Appendix 1, A central limit theorem for incomplete multivariate data (with fj(j) = D^Py -P,)), shows that /Ijhas a large sample normal distribution. Under H a , /Xyconverges to a positive value. Thus, H o is rejected if l/iystd dev(/i r ) from formula 6)| > Z (1 _ aA2) .
This approach can test whether one of the required assumptions for use of the Life Event Table is true. Assumption 2 of the Analysis of This Life-Event Table section can be stated as "the probability to observe Xp) is unrelated to the value of Xfo).
ILLUSTRATIVE EXAMPLES
Recurrent events by age
The Baltimore site of the Multicenter AIDS Cohort Study (BACS) (7) monitored 802 homosexual men not infected with human immunodeficiency virus (HTV) from January 1988 to June 1993. Facial herpes episodes were reported at 6-month visits. Most of these men (n = 597) were aged 29 to less than 50 years at some time during the study.
A Life-Event Table was fit to this data with t 0 = 29 years of age, t m = 50, m = 21, and f, = 30, t 2 = 31, ..., etc. Here, Xfi) is the number of facial herpes episodes for subject j at or after age f,_,, but before age t t . Intermittent follow-up (i.e., kj > 1) occurred. Over all 21 Analysis Intervals, the average n i was 114, and n, was always at least 37; 537 episodes of facial herpes occurred with no single person having more than 11.
The expected cumulative number of facial herpes episodes for a man starting at age 29 and ending at 50 years was computed with 95 percent confidence bands, by the method in the cumulative occurrence section and is shown in figure 1 . Based on the agespecific occurrence of facial herpes in this study, the expected number of facial herpes episodes experienced between ages 29 and 50 years is (Lj-= 5.66 (±0.47 standard error, 95 percent confidence interval 4.73-6.59). Facial herpes occurrence did not change over calendar time, based on visual examination and robust analytic tests (8 However, if age-specific rates changed from calendar or birth cohort effects (2), then the cumulative expectations in figure 1 may not be useful. However, overall age-adjusted herpes rates from January 1988 through June 1993 could still be useful for making comparisons to other groups or time periods. As described in the section, Age-(or time period-) adjusted expectation, uniformly weighting each of the 21 years between ages 29 and 50 years by wt t -1/21 gives facial herpes rates adjusted to a population with equal numbers in each year from ages 29 to <50. This rate was 0.269 episodes per person-year (95 percent confidence interval 0.225-0.314). Figure 1 suggests that younger men may have more facial herpes episodes. The Mantel-Haenszel-type trend test described in the Tests of individual differences section for this pattern gives a Z score of -1.92 = (-5.93/ 3.09) (p -0.06 for significance). A Life-Event Table was fit to these data with m = 16 and t 0 = 0, t l = 0.25, t 2 = 0.50, ..., t l6 = 4.00. Each Analysis Interval spans 0.25 years. If June 1993 occurs before the calendar date that Analysis Interval /, ended for individual j, then Xj(J) is undefined. Otherwise, Xj(i) is zero if person j either died before the interval began (f,_i) and/or had not developed the disease before the interval ended (t t ). Otherwise, Xj(j) is the net amount of time person j survived in interval Ii after a diagnosis of the disease, 0.25 years if the disease was diagnosed before f, -_, and the person survived beyond t t . This formulation is analogous to the reduced sample formulation of Kaplan and Meier (4) and is valid since surviving persons with AIDS in the BACS remained followed until death.
Of 227 subjects, 47 were diagnosed with MAI and 111 with Kaposi's sarcoma by June 1993. Of the 656.0 years of person-study time, 28.1 (4.3 percent) were deleted in incomplete Analysis Intervals. Table 6 gives expected population net times of Kaposi's sarcoma Table. During the first 4 years after AIDS, the expected net times with MAI and Kaposi's sarcoma morbidities are 0.140 years (95 percent confidence interval 0.090-0.190) and 0.545 years (95 percent confidence interval 0.403-0.687), respectively. Every 100 persons who develop AIDS now will produce about 14.0 and 54.5 person-years of MAI and Kaposi's sarcoma morbidity, respectively, during the next 4 years.
The end of the study, June 1993, prevented 109 AIDS cases diagnosed after June 1989 from having a complete 4-year follow-up. Those with initial AIDS diagnoses closer to June 1993 missed more Analysis Intervals. Thus, if disease trends change over calendar time, the probability of missing an Analysis Interval is related to the morbidity experienced in that interval.
The corresponding associations of MAI and Kaposi's sarcoma morbidity with missing Analysis Intervals were tested by the test in the section, Tests of individual differences; P {j was 1 when at least one Analysis Interval was missing (AIDS diagnosiswas after June 1989) and 0 otherwise, and D, was [P, X (1 -P,)]~\ This choice for £>, enables estimation of (HT -^jby) where \x T and \Lj-are the means for those missing at least one Analysis Interval and those missing no Analysis Intervals, respectively. For Kaposi's sarcoma, (^ -\i T^ was 0.100, and the p value for the true difference to be zero was 0.62. For MAI, (/Ltj--iXj-) was 0.113; the p value for being zero was 0.03. Methods of applying the Life-Event Table to MAI, given this finding of nonrandom observation, are addressed in the Discussion.
The Life-Event Table could analyze and compare expenses for treating MAI and Kaposi's sarcoma. Suppose it costs $10,000 and $25,000 per year for Kaposi's sarcoma and MAI maintenance therapy, respectively. For Analysis Interval I t and individual j, let aty and (iy be the Kaposi's sarcoma and MAI morbidity years, respectively. Then, for this person-interval: Xj(i) = $10,000 a t j + $25,000 ft is the total Kaposi's sarcoma and MAI morbidity expense;
Xf\i) = $10,000 a tJ -$25,000 ft, is the excess expense for Kaposi's sarcoma versus MAI disease.
The /i* corresponding to X*(i) in these data is $8,950 (95 percent confidence interval $7,080-$10,830). The expected costs of treating both Kaposi's sarcoma and MAI in the first 4 years after an AIDS diagnosis are $8,950. The /I ** corresponding to Xj* (0 is $1,940 (95 percent confidence interval $10-$3,870); $1,940 more will be spent on Kaposi's sarcoma than on MAI.
Time-varying life measures
The BACS semiannually monitors 82 homosexual men who seroconverted to HTV after entry into the study. The date of HTV seroconversion is approximated by the middate between two semiannual visits. The last HTV-seronegative study visit thus occurred about 3 months before HTV seroconversion, and the first, second, . .., eighth visits after the last seronegative visit occurred about 3, 9, . .., 45 months after seroconversion, respectively.
The Center for Epidemiologic Studies Depression (CES-D) (9) score ranges from 0 to 60 but tends towards 8 in most people. A higher CES-D score indicates depression; scores above 16 suggest clinical depression. CES-D observed at semiannual visits at about 3,9,..., and 45 months after HTV seroconversion should approximate the mean depression status for the surrounding intervals; i.e., 0-6, 7-12,. .. , and 43-48 months, respectively, after seroconversion. In the Life-Event Table formulation: m -8; Analysis Intervals are I x (0-6 months), I 2 (7-12 months), . .., / 8 (43-48 months); and Xfi) is the measure for subject j from the "midpoint" of interval /,-.
Time-averaged expectations over the 4 years, S^t/m, are estimated by S/l/m according to the section, Estimation and Testing from This Life-Event Table. Table 7 gives mean CES-D scores observed in each 6-month interval and the 4-year time-averaged means. These ranged from 7.30 to 11.00, with no trend. Time-averaged mean CES-D over the first 4 
DISCUSSION
The Life-Event Table combines data from nonidentical follow-up periods to estimate cumulative longitudinal and time-period (i.e., age-) adjusted occurrence and derives other simple estimates and tests. It does this for a variety of outcomes including 1) recurrent events; 2) events with different durations; 3) costs; and 4) longitudinal measurements. The method is computationally easy to implement.
The Life-Event Table has few assumptions, but does require random longitudinal observation of outcomes. A statistical test for violation of this assumption was developed in the section, Tests for individual differences. In the section, Expected morbidity years from AIDS diseases, this test indicated that nonrandom observation occurred due to recent calendar period increases in MAI. Given this finding, one could stratify the Life-Event Table analysis by calendar period of initial AIDS diagnosis. If the Life-Event Table is expanded to incorporate covariates, as described later, then covariates related to probability of nonobservation could be utilized. In some settings, it is possible to impute nonrandomly missing values from observed values on the same individual (10) . Such imputed values for nonrandomly missing values could be included in the Life-Event Table that would then adjust for their covariance with the observed values from which they were imputed.
Estimating cumulative occurrence and adjusted occurrence of recurrent and changing time-dependent outcomes has not been well studied. While other approaches to analyze repetitive longitudinal data have been developed (5), the objectives have been to study covariate effects, e.g., Liang and Zeger (8) and Stram et al. (11) , or estimate outcome values at fixed time points, e.g., Priestly and Chao (12), Hastie and Tibshirani (13) , and Rice and Silverman (14) . Still, some of these longitudinal approaches could be extended in given settings to estimate cumulative or adjusted occurrence.
For example, Poisson models (15, 16) could be fit to estimate occurrence of recurrent disease events (i.e., in the section, Recurrent events by age). However, this requires potentially problematic assumptions of independent within-person processes and known prior distribution of the individual intensity parameters (17) . Simple, but powerful, algorithms obtain standardized rates of recurrent events if subjects can be aggregated into independent strata and the longitudinal time point of event is unknown (17) . The Life-Event Table expands upon these by adjusting for intraindividual colinearity and considering changes over an age or time scale.
Expected morbidity time (i.e., the section, Expected mortality years from AIDS diseases) can be estimated with transition models (18, 19) . Transition models also describe transition times, such as time to death from disease or time to death without disease, which the Life-Event Table does not. However, unlike the LifeEvent Table, these models require that all morbidity occur on a contiguous interval, i.e., disease is always followed by a permanent cure or death. Some transition models are also limited by requirements of a Markovian transition process and large, computational resources to obtain variances.
Parametric models have been fit to longitudinal series of life status variables with missing observations (10), such as depression in the section, Time-varying life measures. This could be extended to study timeaveraged levels but requires the events to have a particular multivariate distribution. Such parametric approaches are computationally intensive and are not recommended when substantial numbers of observations are missing (10) .
In addition to applications made in the Illustrative Examples section, the Life-Event Table can be applied to other settings involving partially colinear data. Some possibilities include case-cohort studies (where some cases are represented in the cohort controls); comparing age-adjusted quantities across two chronologic periods (with the same individuals seen at different ages in each period); or obtaining population mean area under the curve serologic levels of compounds from measurement series with missing observations.
The Life-Event From theorem 7.5.4 in Graybill (6), if X/i) and X/i') have a multivariate normal distribution, then S ir is independent of pL t and fi. t .. More information on the distribution of S ir when X/i) and X/i') are multivariate normal has been published (11, 22, 23) . The Life-Event Table must either ignore or adjudicate information from incomplete observation periods. However, let (*'" t' 2 , of the distinct left t' m ') be the ordered set and right time points in This partition (t^, tj,. . . , t^) defines the smallest set of intervals on which each observation,/, will be either completely observed or completely absent. Thus, there is no information loss. In the example of [£(A) + £(AA)] or n u \ 1 + \tr w and hence 5 W -in equation 5 is an unbiased estimate of cr /r . Appendix 1 shows that S ir converges to cr ir . It should be noted that while the estimates in equations 4 and 5 are unbiased, they can have a nonsingularity anomaly; \S ir \ may be larger than 5, • 5,-. This anomaly is not likely unless n iV is small compared with n, and n v . Thus, as equation 3 indicates, the consequences are not great. Estimates of a iV , which avoid this anomaly, are given by BMDP Programs 8D and AM (24) .
